@FiercePharma: Results from Slovenia's Krka show why pharma's so interested in emerging markets. E. European growth push sales up 6%. More | Follow @FiercePharma
@AlisonBFierce: After a year-long voluntary moratorium, researchers are set to resume lab-bred bird flu studies. News | Follow @AlisonBFierce
> Baxter International ($BAX) posted an increase in quarterly earnings on stronger sales, particularly in the U.S. Report
> Roche's ($RHHBY) Avastin won FDA approval for a new use in colorectal cancer patients, in combination with a different chemotherapy regimen to be used after previous Avastin-plus-chemotherapy treatment has failed. Report
> Flush with a new supply contract, South Africa's Cipla Medpro is likely to ask for a higher buyout bid from India's drugmaker Cipla. Report
> Slovenia's Krka saw full-year sales rise 6%, thanks to growth in its eastern European sales, which offset declines in its home country. Report
> India's Lupin won FDA approval for its version of Teva Pharmaceutical's ($TEVA) Plan B contraceptive. Report
> Pfizer's ($PFE) antidepressant Pristiq, a follow-up to its Effexor blockbuster, beat placebo in an 8-week phase IV study; its side effects were "consistent" with previous research, the company said. Report
@FierceMedDev: FDA slaps Class I tag on Bausch + Lomb's eye surgery recall. Report | Follow @FierceMedDev
@DamianFierce: Some companies are passing the cost of the device tax down to customers, and hospitals are none too pleased. Story | Follow @DamianFierce
> AngioDynamics spends $15M on microwave ablation tech. Article
> Recall charges drag down Stryker's strong Q4 sales. Story
Biotech News
@FierceBiotech: Biogen bolsters MS biz with PhIII win for longer-lasting Avonex. News | Follow @FierceBiotech
@JohnCFierce: Flu researchers are getting back to work on controversial genetically engineered viruses, whether US likes it or not. More | Follow @JohnCFierce
@RyanMFierce: Merck CEO pledges to persist with 'good' cholesterol drug program. Story | Follow @RyanMFierce
> Bristol-Myers finds silver (tax) lining after Hep C disaster. News
> Baxter snags hemophilia candidate in $185M deal with Ipsen and broke biotech. Article
Vaccines News
> U.N. excludes vaccine preservative from mercury treaty. More
> Researchers set to resume lab-bred bird flu studies. Report
> Heightened flu season turns focus on vaccine advancements. Story
> Evidence mounts for GSK flu vaccine link to narcolepsy. News
> Novartis lands EU approval of meningitis B vaccine Bexsero. Article
Pharma Manufacturing News
> AmerisourceBergen seeing shifts in drug distribution business. Item
> Drug plants popping up in Kazakhstan. Story
> Counterfeit drug seizures fell significantly in 2012. Report
> Ben Venue consent decree softened to account for drug shortages. News
And Finally... Business leaders in Davos confront the obesity conundrum. Report